U.S. FTC approves Hikma deal for Custopharm with conditions

Argentina Noticias Noticias

U.S. FTC approves Hikma deal for Custopharm with conditions
Argentina Últimas Noticias,Argentina Titulares
  • 📰 Reuters
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 97%

Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. Federal Trade Commission said on Tuesday.

Pharmacists at Hikma Pharmaceuticals package generic versions of ciprofloxacin hydrochloride 750 mg for export to the U.S. and Western markets in Amman, Jordan February 8, 2011. REUTERS/Ali Jarekjihas won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. Federal Trade Commission said on Tuesday.

Hikma, which makes anesthetics, pain medications, sedatives, neuromuscular agents and other drugs, announced the deal in September as a way for it to strengthen its injectable treatments unit in the United States. It was valued at $425 million at that time.Under a deal struck with the FTC, Custopharm's parent company will retain assets related to the corticosteroid drug triamcinolone acetonide, or TCA, by shifting it to another subsidiary.

"Hikma’s acquisition of Custopharm's TCA business could have caused significant harm for patients who use TCA to treat severe skin conditions, allergies, and inflammation," Holly Vedova, director of the FTC’s Bureau of Competition, said in a statement.Reporting by Diane Bartz; Editing by Aurora EllisSign up to our health newsletter to keep up with the latest healthcare trends and pharmaceutical news.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Reuters /  🏆 2. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

SEC Risks Violating Admin Procedure Act by Rejecting Spot Bitcoin ETFs, Says Grayscale – Regulation Bitcoin NewsSEC Risks Violating Admin Procedure Act by Rejecting Spot Bitcoin ETFs, Says Grayscale – Regulation Bitcoin NewsGrayscale Investments' CEO explains that the U.S. Securities and Exchange Commission (SEC) could potentially violate the Administrative Procedure Act by not approving a spot bitcoin exchange-traded fund (ETF).
Leer más »

Commanders deny allegations of financial improprieties in lengthy letter to FTCCommanders deny allegations of financial improprieties in lengthy letter to FTCIn an 18-page letter, the NFL team said allegations by a former employee of long-running financial improprieties are “baseless” and that an investigation is unwarranted.
Leer más »

Another man dies after car crashes into canal in Summit CountyAnother man dies after car crashes into canal in Summit CountyPolice say the third man is in critical condition.
Leer más »

PM Update: Rain continues this evening ahead of a wind-chilled TuesdayPM Update: Rain continues this evening ahead of a wind-chilled TuesdayThe storm passes tonight, but unsettled conditions persist tomorrow.
Leer más »

Florida Chihuahua believed to be world’s oldest dogFlorida Chihuahua believed to be world’s oldest dogThe dog continues to be active despite a mild heart condition.
Leer más »

Shanghai Reports First Covid-19 Deaths Since Start of LockdownShanghai Reports First Covid-19 Deaths Since Start of LockdownShanghai’s health authorities said three Covid-19 patients have died, the first Covid-related deaths to be reported in the city since a widespread outbreak last month prompted a citywide lockdown
Leer más »



Render Time: 2025-04-06 01:41:49